Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/HESTERBIO stock hub

NSE/HESTERBIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/HESTERBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/HESTERBIO

In the news

Latest news · NSE/HESTERBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E34.3

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC7.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/HESTERBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

INR

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	562
Employees Change	-80%
Employees Change Percent	-12.46
Enterprise value	INR 16.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE782E01017
Last refreshed	2026-05-10
Market cap	INR 14B
Price	INR 1,625
Price currency	INR
Rev Per Employee	5,618,967.97x
Sector	Healthcare
Sic	2836
Symbol	nse/HESTERBIO
Website	https://www.hester.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.92%
EV Earnings	39.62x
EV/EBIT	26.35x
EV/EBITDA	20.84x
EV/Sales	5.14x
P/B ratio	4x
P/E ratio	34.27x
P/S ratio	4.44x
PE Ratio10 Y	41.27x
PE Ratio3 Y	57.85x
PE Ratio5 Y	56.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.65%
EBITDA Margin	22.74%
Gross margin	72.21%
Gross Profit	INR 2.3B
Gross Profit Growth	0.68%
Gross Profit Growth Q	10.28%
Gross Profit Growth3 Y	4.75%
Gross Profit Growth5 Y	6.85%
Net Income	INR 409.5M
Net Income Growth	31.46%
Net Income Growth Q	-24.84%
Net Income Growth Years	1%
Net Income Growth3 Y	11.15%
Net Income Growth5 Y	8.3%
Pretax Margin	17.26%
Profit Margin	12.97%
Profit Per Employee	INR 728,594
Profitable Years	20
Roa5y	5.8
Roe5y	11.55
ROIC	7.8
Roic5y	8.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.36%
Cagr1y	-8.49%
Cagr3y	-2.53%
Cagr5y	-5.11%
Div CAGR10	5.49%
Div CAGR3	-4.35%
Div CAGR5	-6.89%
EPS Growth	32.24
EPS Growth Q	-18.42
EPS Growth Years	1
EPS Growth3 Y	9.6
EPS Growth5 Y	8.14
Revenue Growth	-1.15x
Revenue Growth Q	8.99x
Revenue Growth Quarters	1x
Revenue Growth Years	16x
Revenue Growth3 Y	5.06x
Revenue Growth5 Y	9.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 79.4M
Debt	INR 2.1B
Debt EBITDA	INR 2.97
Debt Equity	INR 0.61
Equity	INR 3.5B
Interest Coverage	7.85
Net Cash	INR -2.1B
Net Cash By Market Cap	INR -14.66
Net Debt EBITDA	INR 2.86
Net Debt Equity	INR 0.59
Tangible Book Value	INR 3.3B
Tangible Book Value Per Share	INR 385
WACC	6.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.58%
Dividend Growth	16.67%
Dividend Growth Years	1%
Dividend per share	INR 7
Dividend Years	11
Dividend Yield	0.43%
Ex Div Date	2025-08-06
Last Dividend	INR 7
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	220.62%
1Y total return	-8.48%
200-day SMA	1,679.6
3Y total return	-7.39%
50-day SMA	1,489.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-23.06%
All Time High	3,379
All Time High Change	-51.91%
All Time High Date	2024-07-26
All Time Low	363
All Time Low Change	347.66%
All Time Low Date	2016-02-12
ATR	71.46
Beta	0.43
Ch YTD	1.58
High	1,667.3
High52	2,350
High52 Date	2025-08-04
High52ch	-30.85%
Low	1,625
Low52	1,239.3
Low52 Date	2026-03-30
Low52ch	31.12%
Ma50ch	9.08%
Price vs 200-day SMA	-3.25%
RSI	60.01
RSI Monthly	47.21
RSI Weekly	53.67
Sharpe ratio	-0.18x
Sortino ratio	-0.1
Total Return	1.01%
Tr YTD	1.58
Tr1m	13.88%
Tr1w	-2.38%
Tr3m	7.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 557.4M
Operating Income Growth	6.26
Operating Income Growth Q	55.75
Operating Income Growth3 Y	6.72
Operating Income Growth5 Y	2.73
Operating margin	17.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,658,846%
Shares Insiders	63.75%
Shares Institutions	0.28%
Shares Qo Q	-6.57%
Shares Yo Y	-0.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,825.35x
Bv Per Share	394.1
Ch10y	205.9
Ch1m	13.88
Ch1w	-2.38
Ch1y	-8.8
Ch3m	7.65
Ch3y	-8.36
Ch5y	-24.52
Ch6m	1.45
Change	-0.79%
Change From Open	-0.06
Close	1,638
Days Gap	-0.73
Depreciation Amortization	160,780,000
Dollar Volume	4,886,375
Earnings Date	2026-05-15
EBIT	INR 557.4M
EBITDA	INR 718.1M
EPS	INR 47.83
F Score	2
Fiscal Year End	March
Founded	1,987
Graham Number	658.52178
Graham Upside	-59.48
Income Tax	INR 120.1M
Is Primary Listing	0
Last Earnings Date	2026-01-30
Last Report Date	2025-12-31
Lynch Fair Value	INR 394
Lynch Upside	-75.78
Ma150	1,574.3
Ma150ch	3.22%
Ma20	1,553.6
Ma20ch	4.6%
Next Earnings Date	2026-05-15
Open	1,626
Payment Date	2025-09-12
Position In Range	0
Price Date	2026-05-08
Price EBITDA	INR 19.54
Ptbv Ratio	4.25
Relative Volume	0.52x
Revenue	3,157,860,000x
Tax By Revenue	3.8x
Tax Rate	22.05%
Tr6m	1.45%
Volume	3,007

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/HESTERBIO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$7.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-6.9%

1 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-08-06

Performance

NSE/HESTERBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/HESTERBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+63.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

NSE/HESTERBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.0

Neutral momentum band

Price vs 200-day MA

-3.3%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

-0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/HESTERBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/HESTERBIO stock rating?

nse/HESTERBIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/HESTERBIO analysis?

The full report lives at /stocks/nse/HESTERBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/HESTERBIO?

The latest report frames nse/HESTERBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/HESTERBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.